SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Authors: Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler et al.

Year: 2020

TMPRSS2ProteasesBiologyViral entryVirology

21,210
Citations
2020
Published
10
Authors
Read PDFDOI